Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Drueckes

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|June 19, 2016
Protein Kinase Selectivity Profiling Using Microfluid Mobility Shift AssaysPeter Drueckes
Journal of Biomolecular Screening|December 15, 2010
A fluorescence lifetime-based assay for abelson kinaseStephan Pritz, Gabriele Meder, Klaus Doering, et al.
European Journal of Medicinal Chemistry|December 28, 2019
Promiscuity analysis of a kinase panel screen with designated p38 alpha inhibitorsMariana González-Medina, Filip Miljković, Gernot S Haase, et al.
Analytical Chemistry|December 11, 2008
Affinity classification of kinase inhibitors by mass spectrometric methods and validation using standard IC(50) measurementsMatthias Conradin Jecklin, David Touboul, Rishi Jain, et al.
Bioorganic & Medicinal Chemistry Letters|October 19, 2011
Substrate profiling of IGF-1R and InsR: identification of a potent pentamer substrateJulien Chapelat, Frédéric Berst, Andreas L Marzinzik, et al.
European Journal of Medicinal Chemistry|October 9, 2012
The Substrate-Activity-Screening methodology applied to receptor tyrosine kinases: a proof-of-concept studyJulien Chapelat, Frédéric Berst, Andreas L Marzinzik, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Kinase inhibition by deoxy analogues of the resorcylic lactone L-783277Marc Liniger, Christian Neuhaus, Tatjana Hofmann, et al.
Biochimica Et Biophysica Acta|November 20, 2009
Extended kinase profile and properties of the protein kinase inhibitor nilotinibPaul W Manley, Peter Drueckes, Gabriele Fendrich, et al.
ACS Chemical Biology|July 10, 2015
Type II Inhibitors Targeting CDK2Leila T Alexander, Henrik Möbitz, Peter Drueckes, et al.
Journal of Medicinal Chemistry|September 23, 2011
Discovery of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), a potent and selective inhibitor of the fibroblast growth factor receptor family of receptor tyrosine kinaseVito Guagnano, Pascal Furet, Carsten Spanka, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|June 19, 2016
Protein Kinase Selectivity Profiling Using Microfluid Mobility Shift AssaysPeter Drueckes
Journal of Biomolecular Screening|December 15, 2010
A fluorescence lifetime-based assay for abelson kinaseStephan Pritz, Gabriele Meder, Klaus Doering, et al.
European Journal of Medicinal Chemistry|December 28, 2019
Promiscuity analysis of a kinase panel screen with designated p38 alpha inhibitorsMariana González-Medina, Filip Miljković, Gernot S Haase, et al.
Analytical Chemistry|December 11, 2008
Affinity classification of kinase inhibitors by mass spectrometric methods and validation using standard IC(50) measurementsMatthias Conradin Jecklin, David Touboul, Rishi Jain, et al.
Bioorganic & Medicinal Chemistry Letters|October 19, 2011
Substrate profiling of IGF-1R and InsR: identification of a potent pentamer substrateJulien Chapelat, Frédéric Berst, Andreas L Marzinzik, et al.
European Journal of Medicinal Chemistry|October 9, 2012
The Substrate-Activity-Screening methodology applied to receptor tyrosine kinases: a proof-of-concept studyJulien Chapelat, Frédéric Berst, Andreas L Marzinzik, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Kinase inhibition by deoxy analogues of the resorcylic lactone L-783277Marc Liniger, Christian Neuhaus, Tatjana Hofmann, et al.
Biochimica Et Biophysica Acta|November 20, 2009
Extended kinase profile and properties of the protein kinase inhibitor nilotinibPaul W Manley, Peter Drueckes, Gabriele Fendrich, et al.
ACS Chemical Biology|July 10, 2015
Type II Inhibitors Targeting CDK2Leila T Alexander, Henrik Möbitz, Peter Drueckes, et al.
Journal of Medicinal Chemistry|September 23, 2011
Discovery of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), a potent and selective inhibitor of the fibroblast growth factor receptor family of receptor tyrosine kinaseVito Guagnano, Pascal Furet, Carsten Spanka, et al.
Pageof 2